JOEL GISH: Open Payments
NPI 1306813688 · CHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,642 in 129 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,196 · 2025 $2,642
Food & beverage: $2,642
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $512 |
| AstraZeneca Pharmaceuticals LP | 15 | $376 |
| Novo Nordisk Inc | 16 | $321 |
| Lilly USA, LLC | 18 | $274 |
| GlaxoSmithKline, LLC. | 12 | $243 |
| PFIZER INC. | 13 | $220 |
| Abbott Laboratories | 8 | $137 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| LNHC, Inc | 1 | $65 |
Products named: UBRELVY, TRELEGY ELLIPTA, JARDIANCE, FARXIGA, BREZTRI, FREESTYLE LIBRE, Wegovy, MOUNJARO.
Industry payments across NY — which companies pay providers there.
